227 related articles for article (PubMed ID: 9498744)
1. IL-12 reverses established antigen-specific tolerance of contact sensitivity by affecting costimulatory molecules B7-1 (CD80) and B7-2 (CD86).
Ushio H; Tsuji RF; Szczepanik M; Kawamoto K; Matsuda H; Askenase PW
J Immunol; 1998 Mar; 160(5):2080-8. PubMed ID: 9498744
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte-derived, CD80-mediated costimulation is associated with hapten-specific IgE production during contact hypersensitivity to TH1 haptens.
Burns R; Luzina I; Nasir A; Haidaris CG; Barth RK; Gaspari AA
J Allergy Clin Immunol; 2005 Feb; 115(2):383-90. PubMed ID: 15696100
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
Ritprajak P; Hashiguchi M; Tsushima F; Chalermsarp N; Azuma M
J Immunol; 2010 May; 184(9):4918-25. PubMed ID: 20363965
[TBL] [Abstract][Full Text] [Related]
4. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
5. Blockade of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells.
Katayama I; Matsunaga T; Yokozeki H; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):846-52. PubMed ID: 9217815
[TBL] [Abstract][Full Text] [Related]
6. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
7. Development of IFN-gamma-producing CD8+ gamma delta+ T lymphocytes and IL-2-producing CD4+ alpha beta+ T lymphocytes during contact sensitivity.
Dieli F; Asherson GL; Sireci G; Dominici R; Sciré E; Salerno A
J Immunol; 1997 Mar; 158(6):2567-75. PubMed ID: 9058788
[TBL] [Abstract][Full Text] [Related]
8. Contact hypersensitivity responses following ribavirin treatment in vivo are influenced by type 1 cytokine polarization, regulation of IL-10 expression, and costimulatory signaling.
Tam RC; Lim C; Bard J; Pai B
J Immunol; 1999 Oct; 163(7):3709-17. PubMed ID: 10490966
[TBL] [Abstract][Full Text] [Related]
9. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
Schweitzer AN; Sharpe AH
J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
[TBL] [Abstract][Full Text] [Related]
10. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response.
Greenwald RJ; Lu P; Halvorson MJ; Zhou X; Chen S; Madden KB; Perrin PJ; Morris SC; Finkelman FD; Peach R; Linsley PS; Urban JF; Gause WC
J Immunol; 1997 May; 158(9):4088-96. PubMed ID: 9126967
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of enhanced antigen presentation by B cells activated with anti-mu plus interferon-gamma: role of B7-2 in the activation of naive and memory CD4+ T cells.
Morokata T; Kato T; Igarashi O; Nariuchi H
Eur J Immunol; 1995 Jul; 25(7):1992-8. PubMed ID: 7542599
[TBL] [Abstract][Full Text] [Related]
12. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
Subauste CS; de Waal Malefyt R; Fuh F
J Immunol; 1998 Feb; 160(4):1831-40. PubMed ID: 9469444
[TBL] [Abstract][Full Text] [Related]
13. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo.
Müller G; Saloga J; Germann T; Schuler G; Knop J; Enk AH
J Immunol; 1995 Nov; 155(10):4661-8. PubMed ID: 7594465
[TBL] [Abstract][Full Text] [Related]
14. Costimulation of IL-4 production by murine B7-1 and B7-2 molecules.
Natesan M; Razi-Wolf Z; Reiser H
J Immunol; 1996 Apr; 156(8):2783-91. PubMed ID: 8609397
[TBL] [Abstract][Full Text] [Related]
15. Importance of the B7-2 molecule for low dose melphalan-induced acquisition of tumor-eradicating immunity by mice bearing a large MOPC-315 tumor.
Mokyr MB; Kalinichenko TV; Gorelik L; Bluestone JA
J Immunol; 1998 Feb; 160(4):1866-74. PubMed ID: 9469448
[TBL] [Abstract][Full Text] [Related]
16. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
Ding L; Shevach EM
J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
[TBL] [Abstract][Full Text] [Related]
18. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
George TC; Bilsborough J; Viney JL; Norment AM
Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.
Agrewala JN; Suvas S; Verma RK; Mishra GC
J Immunol; 1998 Feb; 160(3):1067-77. PubMed ID: 9570518
[TBL] [Abstract][Full Text] [Related]
20. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion.
Maxwell JR; Campbell JD; Kim CH; Vella AT
J Immunol; 1999 Feb; 162(4):2024-34. PubMed ID: 9973474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
